Q10160 (Q10160): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
10,279,419.37 Czech koruna
| |||||||||||||||
| Property / EU contribution: 10,279,419.37 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
411,176.77479999996 Euro
| |||||||||||||||
| Property / EU contribution: 411,176.77479999996 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 411,176.77479999996 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 411,176.77479999996 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
15,467,077.0 Czech koruna
| |||||||||||||||
| Property / budget: 15,467,077.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
618,683.08 Euro
| |||||||||||||||
| Property / budget: 618,683.08 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 618,683.08 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 618,683.08 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 16:26, 11 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
10,279,419.37 Czech koruna
0 references
15,467,077.0 Czech koruna
0 references
66.4599999728456 percent
0 references
1 January 2016
0 references
30 June 2019
0 references
EXBIO Praha, a.s.
0 references
49°59'0.49"N, 14°30'9.11"E
0 references
25250
0 references
Projekt je zaměřen na vývoj ucelené řady prototypů lyofilizovaných alergenových extraktů a rekombinantních alergenních komponent pro in vitro diagnostické použití. Novost a unikátnost prototypů tkví ve vlastní technologii lyofilizace alergenů do podoby jednotestového balení každého nového produktu. Lyofilizované alergeny jsou určeny pro cílenou in vitro diagnostiku alergických reakcí pomocí analytických souprav umožňujících sledování specifických buněčných dějů metodou průtokové cytometrie. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_019/0001057
0 references